FDA Authorizes Elanco's CLiK Extra Spray to Combat Screwworm Outbreak
ELAN sits 45% above its 52-week low of $15.5 on elevated volume (2.4× avg).
Summary
The FDA granted Emergency Use Authorization for Elanco's CLiK Extra wound spray to prevent New World Screwworm infestations in livestock and wildlife. This adds a new tool to Elanco's portfolio against the outbreak, following earlier authorizations for Negasunt Powder and Tanidil. The authorization comes as the screwworm reentry into the U.S. poses a critical risk to animal agriculture. Elanco's full product commitment to the outbreak, announced in June, now includes this spray, which will be available through standard channels. The news reinforces Elanco's role in addressing a significant animal health emergency, potentially supporting revenue from its farm animal segment.
At the time of this announcement, ELAN was trading at $22.53 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.3B. The 52-week trading range was $15.50 to $27.98. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.